All Stories

  1. Incentives and disincentives to drug innovation: evidence from recent literature
  2. Clinical trials with multiple endpoints can establish a correlation, but not (yet) causality, between dietary supplementation with omega-3 fatty acids and keratoconjunctivitis sicca
  3. Is medical treatment of Alcohol Withdrawal Syndrome a Stag Hunt? Challenges and opportunities in managing risk and uncertainty in addiction cessation
  4. The Hare Question in Assurance Games: Practical Problems and Insights From Robotic Surgery
  5. Which moral hazard? Health care reform under the Affordable Care Act of 2010
  6. Why Any Seatbelt Mandate is an Infinitely Iterated Prisoner’s Dilemma: A Health Economics Perspective
  7. A Game-Theoretic Model of Marketing Skin Whiteners
  8. Health Services Marketing for Routine Child Vaccinations in the Philippines
  9. Rents From the Essential Health Benefits Mandate of Health Insurance Reform
  10. Autonomy and paternalism in medical e-commerce
  11. Can healthcare solutions form part of the problem? Senegal's dichotomized approach to hepatitis B prevention
  12. Internet medicine and pharmacies: Private choice, public risks, and healthcare business
  13. The skin whitening industry in the Philippines
  14. Pharmacoeconomics and clinical trials in multiple sclerosis: baseline data from the European Union
  15. Multiple Sclerosis: Is Clinical Efficacy Sidetracked by Health Economics?
  16. Transplant Management from a Vendor's Perspective
  17. Aspirin in Cardiovascular and Cerebrovascular Events: Does Market Failure Matter?
  18. A Case Study of Infant Health Promotion and Corporate Marketing of Milk Substitutes
  19. Fluoride-treated water and the problem of merit goods
  20. Colombia’s organ trade: Evidence from Bogotá and Medellín
  21. Kidney black markets and legal transplants: Are they opposite sides of the same coin?
  22. Leptospirosis in the Tropics: When Prevention Doesn’t Easily Sell as a Ton of Cure
  23. Breast Milk Versus Formula: Courts, Health Marketing, and Asymmetric Information
  24. Aspirin in Cardiovascular and Cerebrovascular Events: Does Market Failure Matter?
  25. A Cost-Benefit Analysis of the Legalization of an Informal Health Sector
  26. Promoting Social Welfare Through Oral Health: New Jersey's Fluoridation Experience
  27. Is It Really Medicine? The Traditional and Alternative Medicine Act and Informal Health Economy in the Philippines
  28. Public Health Policy and Medical Missions in the Philippines: The Case of Oral--Facial Clefting